Chi L - Search Results

1

Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.

Yadav V, Chi L, Zhao R, Tourdot BE, Yalavarthi S, Jacobs BN, Banka A, Liao H, Koonse S, Anyanwu AC, Visovatti SH, Holinstat MA, Kahlenberg JM, Knight JS, Pinsky DJ, Kanthi Y. Yadav V, et al. Among authors: chi l. J Clin Invest. 2019 Apr 16;129(7):2872-2877. doi: 10.1172/JCI124804. J Clin Invest. 2019. PMID: 30990798 Free PMC article.

2

Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.

Anyanwu AC, Kanthi Y, Fukase K, Liao H, Mimura T, Desch KC, Gruca M, Kaskar S, Sheikh-Aden H, Chi L, Zhao R, Yadav V, Wakefield TW, Hyman MC, Pinsky DJ. Anyanwu AC, et al. Among authors: chi l. Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):e118-e129. doi: 10.1161/ATVBAHA.119.312407. Arterioscler Thromb Vasc Biol. 2019. PMID: 30816804 Free PMC article.

3

A novel model of venous thrombosis in the vena cava of rabbits.

Chi L, Saganek LJ, Rogers KL, Mertz TE, Metz AL, Uprichard AC, Gallagher KP. Chi L, et al. J Pharmacol Toxicol Methods. 1998 Jun;39(4):193-202. doi: 10.1016/s1056-8719(98)00024-0. J Pharmacol Toxicol Methods. 1998. PMID: 9845298

4

Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits.

Chi L, Gibson G, Peng YW, Bousley R, Brammer D, Rekhter M, Chen J, Leadley R. Chi L, et al. J Thromb Haemost. 2004 Jan;2(1):85-92. doi: 10.1111/j.1538-7836.2004.00547.x. J Thromb Haemost. 2004. PMID: 14717971 Free article.

5

Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran.

Chi L, Mertz TE, Rogers KL, Janiczek N, Peng YW, Saganek L, Bousley RF, Juneau PL, Uprichard AC, Gallagher KP. Chi L, et al. J Thromb Thrombolysis. 2001 Feb;11(1):19-31. doi: 10.1023/a:1008900109285. J Thromb Thrombolysis. 2001. PMID: 11248787

6

Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis.

Rogers KL, Chi L, Rapundalo ST, Kramer JB, Gallagher KP. Rogers KL, et al. Among authors: chi l. Basic Res Cardiol. 1999 Feb;94(1):15-22. doi: 10.1007/s003950050122. Basic Res Cardiol. 1999. PMID: 10097826

7

Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.

Leadley RJ Jr, Chi L, Rebello SS, Gagnon A. Leadley RJ Jr, et al. Among authors: chi l. J Pharmacol Toxicol Methods. 2000 Mar-Apr;43(2):101-16. doi: 10.1016/s1056-8719(00)00095-2. J Pharmacol Toxicol Methods. 2000. PMID: 11150738 Review.

8

Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.

Willardsen JA, Dudley DA, Cody WL, Chi L, McClanahan TB, Mertz TE, Potoczak RE, Narasimhan LS, Holland DR, Rapundalo ST, Edmunds JJ. Willardsen JA, et al. Among authors: chi l. J Med Chem. 2004 Jul 29;47(16):4089-99. doi: 10.1021/jm0497491. J Med Chem. 2004. PMID: 15267248

9

Assessment of ex vivo pharmacodynamic markers during inhibition of thrombosis by CI-1031 (ZK-807834), a novel direct factor Xa inhibitor.

Chi L, Pen YW, Potoczak R, Gibson G, Hicks G, Mertz TE, Janiczek N, Juneau PL, Gallagher K, Leadley R. Chi L, et al. Pharmacology. 2002 Feb;64(2):76-83. doi: 10.1159/000056154. Pharmacology. 2002. PMID: 11803247

10

In vitro and in vivo antithrombotic activity of PD-198961, a novel synthetic factor Xa inhibitor.

Chi L, Peng YW, Gibson G, Hicks G, Mertz TE, Rapundalo S, Janiczek N, Edmunds JJ, Leadley R. Chi L, et al. J Cardiovasc Pharmacol. 2004 Oct;44(4):493-500. doi: 10.1097/01.fjc.0000141475.14007.ab. J Cardiovasc Pharmacol. 2004. PMID: 15454859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,286 results

Search Page